Investing in healthtech to tackle Indonesia’s greatest challenges
The COVID-19 pandemic has exposed critical gaps in Indonesia’s healthcare infrastructure, revealing structural and systemic shortcomings that will require scalable solutions. Change doesn't happen overnight, particularly for the healthcare sector, which consists of multiple intertwined industries with strict regulatory oversight. But precisely because the industry is highly regulated, regulations play a huge role in shaping trends.
AMILI, a precision gut microbiome firm, raises new funding led by East Ventures
AMILI, Southeast Asia’s first and only precision gut microbiome company, today announced that it has secured new funding from East Ventures, a pioneering sector-agnostic venture capital firm that has supported over 300 tech companies across Southeast Asia. This fund strengthens AMILI’s balance sheet, following the company’s series A funding in June 2022.